Cadre (NYSE:CDRE) Price Target Raised to $45.00

Дата публикации: 10-08-2026 05:36:50

Cadre (NYSE:CDRE – Free Report) had its target price lifted by JPMorgan Chase & Co. from $40.00 to $45.00 in a research note released on Friday morning,Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts have also weighed in on CDRE. Zacks Research raised Cadre from a “strong sell” […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Genpact (NYSE:G) Price Target Raised to $45.00	0	14.26	10-08-2026
2	Qiagen (NYSE:QGEN) Price Target Raised to $50.00	0	14.26	10-08-2026
3	JFrog (NASDAQ:FROG) Price Target Raised to $115.00	0	14.6	10-08-2026
4	Cencora (NYSE:COR) Price Target Raised to $390.00	0	11.9	10-08-2026
5	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
6	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
7	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
8	Maplebear (NASDAQ:CART) Price Target Raised to $62.00	0	13.46	10-08-2026
9	Banco De Chile (NYSE:BCH) Price Target Raised to $45.00	0	14.2	10-08-2026
10	CACI International (NYSE:CACI) Price Target Raised to $715.00	0	14.65	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.85. Источник: www.americanbankingnews.com.